The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Secora Michael since 2023.
This trader's CIK number is 1855980.
At the time of last reporting, Secora Michael was the Chief Financial Officer of Recursion Pharmaceuticals, Inc.. (stock ticker symbol RXRX).
Also see all insider trading activities at Recursion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | RXRX | 0 | $0 | 328,124 | $2,713,004 | 697,500 | $1,548,444 |
| 2023 | RXRX | 0 | $0 | 350,000 | $3,175,900 | 525,000 | $1,165,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-12 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-11-13 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-11-12 | RXRX | Sale | 15,000 | 7.64 | 114,630 |
| 2024-11-13 | RXRX | Sale | 15,000 | 7.66 | 114,870 |
| 2024-10-09 | RXRX | Sale | 15,000 | 6.36 | 95,370 |
| 2024-10-08 | RXRX | Sale | 15,000 | 6.32 | 94,755 |
| 2024-10-09 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-10-08 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-09-11 | RXRX | Sale | 15,000 | 6.32 | 94,725 |
| 2024-09-10 | RXRX | Sale | 15,000 | 6.17 | 92,505 |
| 2024-09-11 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-09-10 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-08-13 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-08-14 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-08-13 | RXRX | Sale | 15,000 | 6.35 | 95,190 |
| 2024-08-14 | RXRX | Sale | 15,000 | 6.35 | 95,250 |
| 2024-07-10 | RXRX | Sale | 15,000 | 7.24 | 108,570 |
| 2024-07-09 | RXRX | Sale | 15,000 | 7.32 | 109,785 |
| 2024-07-10 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-07-09 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-06-13 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-06-14 | RXRX | Option Ex | 39,375 | 2.22 | 87,412 |
| 2024-06-13 | RXRX | Sale | 15,000 | 9.32 | 139,800 |
| 2024-06-14 | RXRX | Sale | 15,000 | 9.27 | 139,080 |
| 2024-04-16 | RXRX | Sale | 25,000 | 7.67 | 191,650 |
| 2024-04-17 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2024-04-16 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2024-04-17 | RXRX | Sale | 23,124 | 7.58 | 175,349 |
| 2024-03-12 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2024-03-13 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2024-03-12 | RXRX | Sale | 25,000 | 10.46 | 261,375 |
| 2024-03-13 | RXRX | Sale | 25,000 | 11.03 | 275,825 |
| 2024-02-14 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2024-02-13 | RXRX | Sale | 25,000 | 9.86 | 246,550 |
| 2024-02-14 | RXRX | Sale | 25,000 | 10.71 | 267,725 |
| 2024-02-13 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-12-13 | RXRX | Sale | 25,000 | 7.59 | 189,775 |
| 2023-12-12 | RXRX | Sale | 25,000 | 7.39 | 184,875 |
| 2023-12-13 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-12-12 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-11-15 | RXRX | Sale | 25,000 | 7.43 | 185,850 |
| 2023-11-14 | RXRX | Sale | 25,000 | 6.32 | 157,950 |
| 2023-11-15 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-11-14 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-10-10 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-10-11 | RXRX | Sale | 25,000 | 6.85 | 171,325 |
| 2023-10-10 | RXRX | Sale | 25,000 | 7.07 | 176,775 |
| 2023-10-11 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-09-12 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-09-13 | RXRX | Sale | 25,000 | 8.69 | 217,325 |
| 2023-09-12 | RXRX | Sale | 25,000 | 8.43 | 210,625 |
| 2023-09-13 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-08-16 | RXRX | Sale | 25,000 | 8.90 | 222,525 |
| 2023-08-15 | RXRX | Sale | 25,000 | 9.27 | 231,800 |
| 2023-08-16 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-08-15 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-07-19 | RXRX | Sale | 25,000 | 15.24 | 381,025 |
| 2023-07-18 | RXRX | Sale | 25,000 | 13.84 | 345,900 |
| 2023-07-18 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-07-19 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-06-14 | RXRX | Sale | 25,000 | 10.07 | 251,850 |
| 2023-06-13 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-06-14 | RXRX | Option Ex | 37,500 | 2.22 | 83,250 |
| 2023-06-13 | RXRX | Sale | 25,000 | 9.93 | 248,300 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Secora Michael (Chief Financial Officer of Recursion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.